Tag Archives: Despite

FDA Approves Powerful New Opioid, Dsuvia (Sufentanil), Despite Criticisms

Print this page FRIDAY, Nov. 2, 2018 — Ruling against the recommendation of one of its chief experts, the U.S. Food and Drug Administration on Friday approved an extremely potent new opioid painkiller, Dsuvia. The drug is a 30-microgram pill that packs the same punch as 5 milligrams of intravenous morphine, according to the Washington… Read More »